Literature DB >> 27446458

Carcinoma-like nonfunctional pheochromocytoma in the right adrenal gland: A case report.

Shingo Moriyama1, Hideki Takeshita1, Saori Araki1, Takuo Tokairin2, Makoto Kagawa1, Koji Chiba1, Akiko Adachi2, Akira Noro1.   

Abstract

Evaluation of the malignant potential of a pheochromocytoma (PCC) remains controversial. PCC is regarded as a neuroendocrine tumor (NET), and the classification of NETs has gradually been defined over the last decade, particularly for gastroenteropancreatic NET. The present study describes a case of locally advanced, carcinoma-like, nonfunctional PCC, which may be regarded as neuroendocrine carcinoma (NEC) rather than a malignant PCC. A 72-year-old man was referred to Saitama Red Cross Hospital (Saitama, Japan), presenting with a 2-month history of right flank pain. Computed tomography revealed a right adrenal gland tumor, which measured 6.0 cm in diameter, invading the hilum of the right kidney, liver and inferior vena cava (IVC). Radical surgery was performed with en bloc resection of the right kidney, and adjacent parts of the liver and IVC. Immunohistochemical examination demonstrated that all of the resected tissues were positive for cytokeratin AE1/AE3, chromogranin A, synaptophysin, cluster of differentiation 56 and Ki-67, and the specimen had a Ki-67 index of 80%. A diagnosis of carcinoma-like PCC or NEC of the adrenal gland was confirmed. Reports of NEC of the adrenal gland are extremely rare in the literature, and classification of PCC as a NET has not yet been fully discussed. The present case may therefore contribute to the classification of NETs in the adrenal gland.

Entities:  

Keywords:  Ki-67; adrenal gland neoplasms; malignant pheochromocytoma; neuroendocrine carcinoma; neuroendocrine tumor; pheochromocytoma

Year:  2016        PMID: 27446458      PMCID: PMC4950732          DOI: 10.3892/ol.2016.4776

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

Review 1.  Neuroendocrine tumors of the gastro-entero-pancreatic system.

Authors:  Sara Massironi; Valentina Sciola; Maddalena Peracchi; Clorinda Ciafardini; Matilde Pia Spampatti; Dario Conte
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Neuroendocrine tumors, version 1.2015.

Authors:  Matthew H Kulke; Manisha H Shah; Al B Benson; Emily Bergsland; Jordan D Berlin; Lawrence S Blaszkowsky; Lyska Emerson; Paul F Engstrom; Paul Fanta; Thomas Giordano; Whitney S Goldner; Thorvardur R Halfdanarson; Martin J Heslin; Fouad Kandeel; Pamela L Kunz; Boris W Kuvshinoff; Christopher Lieu; Jeffrey F Moley; Gitonga Munene; Venu G Pillarisetty; Leonard Saltz; Julie Ann Sosa; Jonathan R Strosberg; Jean-Nicolas Vauthey; Christopher Wolfgang; James C Yao; Jennifer Burns; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2015-01       Impact factor: 11.908

Review 3.  Pheochromocytomas and paragangliomas: assessment of malignant potential.

Authors:  Tim I M Korevaar; Ashley B Grossman
Journal:  Endocrine       Date:  2011-10-25       Impact factor: 3.633

4.  Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome.

Authors:  Henning Jann; Stephanie Roll; Anne Couvelard; Olivia Hentic; Marianne Pavel; Jacqueline Müller-Nordhorn; Martin Koch; Christoph Röcken; Guido Rindi; Philippe Ruszniewski; Bertram Wiedenmann; Ulrich-Frank Pape
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

5.  Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?

Authors:  E van der Harst; H A Bruining; H Jaap Bonjer; F van der Ham; W N Dinjens; S W Lamberts; W W de Herder; J W Koper; T Stijnen; C Proye; M Lecomte-Houcke; F T Bosman; R R de Krijger
Journal:  J Pathol       Date:  2000-06       Impact factor: 7.996

6.  Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma.

Authors:  Carsten Boltze; Jochen Mundschenk; Nicole Unger; Regine Schneider-Stock; Brigitte Peters; Christian Mawrin; Cuong Hoang-Vu; Albert Roessner; Hendrik Lehnert
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

Review 7.  Subclinical phaeochromocytoma.

Authors:  Massimo Mannelli; Jacques W M Lenders; Karel Pacak; Gabriele Parenti; Graeme Eisenhofer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

8.  A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.

Authors:  M Mannelli; C Pupilli; R Lanzillotti; L Ianni; A Amorosi; G Credi; C Pratesi
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

9.  Cytokeratin expression in adrenal phaeochromocytomas and extra-adrenal paragangliomas.

Authors:  R Chetty; P Pillay; V Jaichand
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

10.  Genitourinary small-cell carcinoma: 11-year treatment experience.

Authors:  Kun Chang; Bo Dai; Yun-Yi Kong; Yuan-Yuan Qu; Hua-Lei Gan; Wei-Jie Gu; Ding-Wei Ye; Hai-Liang Zhang; Yao Zhu; Guo-Hai Shi
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.